Platelet Changes in Acute Leukemia
- 261 Downloads
Acute leukemia is a hematopoietic stem cell malignant disease, with abnormal proliferation of leukemic and immature cells that suppress the production of normal blood cells and extensively invade peripheral tissues. The bleeding complications are very common in acute leukemia and often lead to death. One major cause for hemorrhage is thrombocytopenia, which is caused by the replacement of normal bone marrow cells with leukemic cells and the inhibition of megakaryocytes functions. Declines in platelet count as well as in function in acute leukemia have been reported in many studies. Here, we reviewed the literatures concerning platelet changes in acute leukemia.
KeywordsChanges of platelet Acute leukemia Research progress
We are thankful to the Education Bureau of Sichuan Province for financial support (Grant No. 11ZA150).
Conflict of interest
Authors have no conflict of interest.
- 1.Deutsch, V., Katz, B. Z., & Tomer, A. (2010). Megakaryocyte development and platelet production in normal and disease states. Harefuah, 149(291–297), 336.Google Scholar
- 4.Ntaios, G., Papadopoulos, A., Chatzinikolaou, A., Saouli, Z., Karalazou, P., Kaiafa, G., et al. (2008). Increased values of mean platelet volume and platelet size deviation width may provide a safe positive diagnosis of idiopathic thrombocytopenic purpura. Acta Haematologica, 119, 173–177.PubMedCrossRefGoogle Scholar
- 8.Zeidler, L., Zimmermann, M., Moricke, A., Meissner, B., Bartels, D., Tschan, C., et al. (2012). Low platelet counts after induction therapy for childhood acute lymphoblastic leukemia are strongly associated with poor early response to treatment as measured by minimal residual disease and are prognostic for treatment outcome. Haematologica, 97, 402–409.PubMedCrossRefGoogle Scholar
- 9.Alatrash, G., Pelosini, M., Saliba, R. M., Koca, E., Rondon, G., Andersson, B. S., et al. (2011). Platelet recovery before allogeneic stem cell transplantation predicts posttransplantation outcomes in patients with acute myelogenous leukemia and myelodysplastic syndrome. Biology of Blood and Marrow Transplantation, 17, 1841–1845.PubMedCrossRefGoogle Scholar
- 10.Psaila, B., Bussel, J. B., Frelinger, A. L., Babula, B., Linden, M. D., Li, Y., et al. (2001). Differences in platelet function in patients with acute myeloid leukemia and myelodysplasia compared to equally thrombocytopenic patients with immune thrombocytopenia. Journal of Thrombosis and Haemostasis, 9, 2302–2310.CrossRefGoogle Scholar
- 11.Strauss, G., Vollert, C., von Stackelberg, A., Weimann, A., Gaedicke, G., & Schulze, H. (2011). Immature platelet count: A simple parameter for distinguishing thrombocytopenia in pediatric acute lymphocytic leukemia from immune thrombocytopenia. Pediatric Blood & Cancer, 57, 641–647.CrossRefGoogle Scholar
- 15.Ryningen, A., Apelseth, T., Hausken, T., & Bruserud, O. (2006). Reticulated platelets are increased in chronic myeloproliferative disorders, pure erythrocytosis, reactive thrombocytosis and prior to hematopoietic reconstitution after intensive chemotherapy. Platelets, 17, 296–302.PubMedCrossRefGoogle Scholar
- 19.Popov, V., Vladareanu, A., Bumbea, H., Radesi, S., Iordache, M., Kovacs, E., et al. (2010). Membrane fluidity’s role in platelet function in patients with myeloproliferative neoplasms. Blood (ASH Annual Meeting Abstracts), 116, Abstract 5125.Google Scholar
- 27.Leinoe, E. B., Hoffmann, M. H., Kjaersgaard, E., Nielsen, J. D., Bergmann, O. J., Klausen, T. W., et al. (2005). Prediction of haemorrhage in the early stage of acute myeloid leukaemia by flow cytometric analysis of platelet function. British Journal of Haematology, 128, 526–532.PubMedCrossRefGoogle Scholar
- 28.Foss, B., Ulvestad, E., Hervig, T., & Bruserud, O. (2002). Effects of cytarabine and various anthracycline on platelet activation: Characterization of in vitro effects and their possible clinical relevance in acute myelogenous leukemia. International Journal of Cancer, 97, 106–114.CrossRefGoogle Scholar